References:
1. Main KM et al.
CushingÕs syndrome due to pharmacological interaction in a cystic fibrosis
patient. Acta Paediatr. 2002;91:1008-1011.
2. De Wachter E et al.
Rapidly developing Cushing syndrome in a 4-year-old patient during combined
treatment with itraconazole and inhaled budesonide. Eur J Pediatr.
2003;162:488-489.
3. Bolland MJ et al.
CushingÕs syndrome due to interaction between inhaled corticosteroids and
itraconazole. Ann Pharmacother. 2004;38:46-49.
4. Clevenbergh P et al.
Iatrogenic CushingÕs syndrome in an HIM-infected patient treated with inhaled
corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI
containing regimen. J Infect. 2002;44:194-195.
5. Gupta SK, Dube MP.
Exogenous cushing syndrome mimicking human immunodeficiency virus
lipodystrophy. Clin Infect Dis. 2002;15:E69-71.
6. Rouanet I et al.
CushingÕs syndrome in a patient treated by ritonavir/lopinavir and inhaled
fluticasone. HIV Med. 2003;4:149-150.
7. Raaska K et al.
Plasma concentrations of inhaled budesonide and its effects on plasma cortisol
are increased by the cytochrome P4503A4 inhibitor itraconazole. Clin Pharmacol
Ther. 2002;72:362-369.
8. Hillebrand-Haverkort
ME et al. Ritonavir-induced CushingÕs syndrome in a patient treated with nasal
fluticasone. AIDS. 1999;10:1803.
9. Chen F et al.
CushingÕs syndrome and severe adrenal suppression in patients treated with
ritonavir and inhaled nasal fluticasone. Sex Transm Infect. 1999;75:274.